219 related articles for article (PubMed ID: 25154907)
1. Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2.
Chen M; Zhou H; Cheng N; Qian F; Ye RD
Immunobiology; 2014 Dec; 219(12):916-23. PubMed ID: 25154907
[TBL] [Abstract][Full Text] [Related]
2. Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1.
Abouelasrar Salama S; De Bondt M; De Buck M; Berghmans N; Proost P; Oliveira VLS; Amaral FA; Gouwy M; Van Damme J; Struyf S
Front Immunol; 2020; 11():843. PubMed ID: 32477346
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Lipopolysaccharide-Induced Inflammatory Response by Fragments from Serum Amyloid A.
Zhou H; Chen M; Zhang G; Ye RD
J Immunol; 2017 Aug; 199(3):1105-1112. PubMed ID: 28674180
[TBL] [Abstract][Full Text] [Related]
4. Matrix Metalloproteinase-9-Generated COOH-, but Not NH
Gouwy M; De Buck M; Abouelasrar Salama S; Vandooren J; Knoops S; Pörtner N; Vanbrabant L; Berghmans N; Opdenakker G; Proost P; Van Damme J; Struyf S
Front Immunol; 2018; 9():1081. PubMed ID: 29915572
[TBL] [Abstract][Full Text] [Related]
5. Expression of mouse apolipoprotein SAA1.1 in CE/J mice: isoform-specific effects on amyloidogenesis.
Yu J; Zhu H; Guo JT; de Beer FC; Kindy MS
Lab Invest; 2000 Dec; 80(12):1797-806. PubMed ID: 11140693
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.
Srinivasan S; Patke S; Wang Y; Ye Z; Litt J; Srivastava SK; Lopez MM; Kurouski D; Lednev IK; Kane RS; Colón W
J Biol Chem; 2013 Jan; 288(4):2744-55. PubMed ID: 23223242
[TBL] [Abstract][Full Text] [Related]
7. AA amyloidosis-resistant CE/J mice have Saa1 and Saa2 genes that encode an identical SAA isoform.
Mori M; Tiang G; Higuchi K
Amyloid; 2014 Mar; 21(1):1-8. PubMed ID: 24228751
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity.
Smole U; Gour N; Phelan J; Hofer G; Köhler C; Kratzer B; Tauber PA; Xiao X; Yao N; Dvorak J; Caraballo L; Puerta L; Rosskopf S; Chakir J; Malle E; Lane AP; Pickl WF; Lajoie S; Wills-Karp M
Nat Immunol; 2020 Jul; 21(7):756-765. PubMed ID: 32572240
[TBL] [Abstract][Full Text] [Related]
9. COOH-terminal SAA1 peptides fail to induce chemokines but synergize with CXCL8 and CCL3 to recruit leukocytes via FPR2.
De Buck M; Gouwy M; Berghmans N; Opdenakker G; Proost P; Struyf S; Van Damme J
Blood; 2018 Jan; 131(4):439-449. PubMed ID: 29371208
[TBL] [Abstract][Full Text] [Related]
10. Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties.
Takase H; Tanaka M; Miyagawa S; Yamada T; Mukai T
Biochem Biophys Res Commun; 2014 Jan; 444(1):92-7. PubMed ID: 24440699
[TBL] [Abstract][Full Text] [Related]
11. Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2.
Thorn CF; Whitehead AS
J Immunol; 2002 Jul; 169(1):399-406. PubMed ID: 12077270
[TBL] [Abstract][Full Text] [Related]
12. Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells.
Chami B; Barrie N; Cai X; Wang X; Paul M; Morton-Chandra R; Sharland A; Dennis JM; Freedman SB; Witting PK
Int J Mol Sci; 2015 May; 16(5):11101-24. PubMed ID: 25988387
[TBL] [Abstract][Full Text] [Related]
13. PTX3, a key component of innate immunity, is induced by SAA via FPRL1-mediated signaling in HAECs.
Dong Z; An F; Wu T; Zhang C; Zhang M; Zhang Y; An G; An F
J Cell Biochem; 2011 Aug; 112(8):2097-105. PubMed ID: 21465531
[TBL] [Abstract][Full Text] [Related]
14. Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines.
Gouwy M; De Buck M; Pörtner N; Opdenakker G; Proost P; Struyf S; Van Damme J
Eur J Immunol; 2015 Jan; 45(1):101-12. PubMed ID: 25345597
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid A stimulates lipoprotein-associated phospholipase A2 expression in vitro and in vivo.
Li B; Dong Z; Liu H; Xia YF; Liu XM; Luo BB; Wang WK; Li B; Gao F; Zhang C; Zhang MX; Zhang Y; An FS
Atherosclerosis; 2013 Jun; 228(2):370-9. PubMed ID: 23623642
[TBL] [Abstract][Full Text] [Related]
16. Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands.
Abouelasrar Salama S; Gouwy M; Van Damme J; Struyf S
Front Endocrinol (Lausanne); 2023; 14():1119227. PubMed ID: 36817589
[TBL] [Abstract][Full Text] [Related]
17. Serum amyloid A1 alleles and plasma concentrations of serum amyloid A.
Yamada T; Wada A; Itoh Y; Itoh K
Amyloid; 1999 Sep; 6(3):199-204. PubMed ID: 10524285
[TBL] [Abstract][Full Text] [Related]
18. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system.
Hagihara K; Nishikawa T; Isobe T; Song J; Sugamata Y; Yoshizaki K
Biochem Biophys Res Commun; 2004 Feb; 314(2):363-9. PubMed ID: 14733913
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.
Dufton N; Hannon R; Brancaleone V; Dalli J; Patel HB; Gray M; D'Acquisto F; Buckingham JC; Perretti M; Flower RJ
J Immunol; 2010 Mar; 184(5):2611-2619. PubMed ID: 20107188
[TBL] [Abstract][Full Text] [Related]
20. Expression of SAA1, SAA2 and SAA4 genes in human primary monocytes and monocyte-derived macrophages.
Jumeau C; Awad F; Assrawi E; Cobret L; Duquesnoy P; Giurgea I; Valeyre D; Grateau G; Amselem S; Bernaudin JF; Karabina SA
PLoS One; 2019; 14(5):e0217005. PubMed ID: 31100086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
